articleTop 1% cited
National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age
Urology · 2011 · Vol. 77(5) · pp. 1081–1087
Karin S. Coyne✉(Health Outcomes Solutions (United States))Christopher Sexton(Health Outcomes Solutions (United States))Vasudha Vats(Pfizer (United States))Christine Thompson(Health Outcomes Solutions (United States))Zoë Kopp(Pfizer (United States))Ian Milsom(University of Gothenburg)
Urinary Bladder and Prostate ResearchPelvic floor disorders treatmentsUrinary Tract Infections ManagementMedicineOveractive bladderUrologyDemographyPathologyAlternative medicine
MeSH terms
AdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesUnited StatesPrevalenceAge DistributionSex DistributionUrinary Bladder, Overactive
Funding
- Pfizer
Citations
364
FWCI
18.31
field-weighted impact
References
15
Percentile
100%
vs. same field & year
Citations per year
Cited by
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
The Journal of Urology · 2012 · 699 citations
References
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
European Urology · 2006 · 2,575 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.